Prognostic Significance of the Systemic Inflammation Response Index in Gastrointestinal Malignancy Patients: A pooled Analysis of 10,091 Participants

References

• Sung H , FerlayJ, SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Arnold M , AbnetCC, NealeREet al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology159(1), 335–349 (2020).
   PubMed Web of Science ®Google Scholar
• Chen F , XieC, RenK, XuX. Prognostic value of the Naples Prognostic Score in patients with gastrointestinal cancers: a meta-analysis. Nutr. Cancer75(7), 1–11 (2023).
   PubMed Web of Science ®Google Scholar
• Atasever Akkas E , ErdisE, YucelB. Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer. Eur. Arch. Otorhinolaryngol.280(8), 3821–3830 (2023).
   PubMed Web of Science ®Google Scholar
• Pang H , ZhangW, LiangXet al. Prognostic score system using preoperative inflammatory, nutritional and tumor markers to predict prognosis for gastric cancer: a two-center cohort study. Adv. Ther.38(9), 4917–4934 (2021).
   PubMed Web of Science ®Google Scholar
• Zhao X , ZhouY, LiuBet al. Preoperative neutrophil–lymphocyte ratio (NLR)–binding fibrinogen–albumin ratio (FAR) is superior to platelet–lymphocyte ratio (PLR)–binding fibrinogen–albumin ratio (FAR) and lymphocyte–monocyte (LMR)–binding fibrinogen–albumin ratio (FAR) as predictors of survival in surgical patients with colorectal adenocarcinoma. Med. Sci. Monit.29, e939442 (2023).
   PubMed Web of Science ®Google Scholar
• Liu S , LiZ, GuoW, FanY. Predictive value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio esophageal stricture after endoscopic submucosal dissection of early esophageal cancer. Med. Sci. Monit.29, e940041 (2023).
   PubMed Web of Science ®Google Scholar
• Li B , ZhouP, LiuYet al. Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis. Clin. Chim. Acta483, 48–56 (2018).
   PubMed Web of Science ®Google Scholar
• Chen L , ChenY, ZhangLet al. In gastric cancer patients receiving neoadjuvant chemotherapy systemic inflammation response index is a useful prognostic indicator. Pathol. Oncol. Res.27, 1609811 (2021).
   PubMed Web of Science ®Google Scholar
• Chu Y , LiuY, JiangYet al. Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: development and validation of the systemic inflammation response index-covered score. Cancer Med.12(8), 9570–9582 (2023).
   PubMed Web of Science ®Google Scholar
• Cao Y , ZhengX, HuYet al. Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer. Cell Death Dis.14(1), 69 (2023).
   PubMed Web of Science ®Google Scholar
• Chen Y , JinM, ShaoY, XuG. Prognostic value of the systemic inflammation response index in patients with adenocarcinoma of the oesophagogastric junction: a propensity score-matched analysis. Dis. Markers2019, 4659048 (2019).
   PubMed Web of Science ®Google Scholar
• Qi Q , ZhuangL, ShenYet al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer122(14), 2158–2167 (2016).
   PubMed Web of Science ®Google Scholar
• Zheng Y , ChenY, ChenJet al. Combination of systemic inflammation response index and platelet-to-lymphocyte ratio as a novel prognostic marker of upper tract urothelial carcinoma after radical nephroureterectomy. Front. Oncol.9, 914 (2019).
   PubMed Web of Science ®Google Scholar
• Hu M , XuQ, YangSet al. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study. Ann. Transl. Med.8(20), 1310 (2020).
   PubMed Web of Science ®Google Scholar
• Valero C , PardoL, SansaAet al. Prognostic capacity of systemic inflammation response index (SIRI) in patients with head and neck squamous cell carcinoma. Head Neck42(2), 336–343 (2020).
   PubMed Web of Science ®Google Scholar
• Page MJ , McKenzieJE, BossuytPMet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, n71 (2021).
   PubMed Web of Science ®Google Scholar
• Lin Y , LiuZ, QiuYet al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis. Eur. J. Surg. Oncol.44(10), 1494–1503 (2018).
   PubMed Web of Science ®Google Scholar
• Pang HY , YanMH, ChenLHet al. Detection of asymptomatic recurrence following curative surgery improves survival in patients with gastric cancer: a systematic review and meta-analysis. Front. Oncol.12, 1011683 (2022).
   PubMed Web of Science ®Google Scholar
• Yang XC , LiuH, LiuDCet al. Prognostic value of pan-immune-inflammation value in colorectal cancer patients: a systematic review and meta-analysis. Front. Oncol.12, 1036890 (2022).
   PubMedGoogle Scholar
• Tierney JF , StewartLA, GhersiDet al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials8, 16 (2007).
   PubMed Web of Science ®Google Scholar
• Cui S , CaoS, ChenQet al. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Front. Immunol.14, 1118053 (2023).
   PubMed Web of Science ®Google Scholar
• Gao W , ZhangF, MaT, HaoJ. High preoperative fibrinogen and systemic inflammation response index (F-SIRI) predict unfavorable survival of resectable gastric cancer patients. J. Gastric Cancer20(2), 202–211 (2020).
   PubMed Web of Science ®Google Scholar
• Geng Y , ZhuD, WuCet al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int. Immunopharmacol.65, 503–510 (2018).
   PubMed Web of Science ®Google Scholar
• Jin B , HuW, SuSet al. The prognostic value of systemic inflammation response index in cholangiocarcinoma patients. Cancer Manag. Res.13, 6263–6277 (2021).
   PubMed Web of Science ®Google Scholar
• Kamposioras K , PapaxoinisG, DawoodMet al. Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy. Acta Oncol.61(5), 583–590 (2022).
   PubMed Web of Science ®Google Scholar
• Kim JS , ChoiM, KimSHet al. Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic cancer following neoadjuvant chemotherapy. Pancreatology22(7), 987–993 (2022).
   PubMed Web of Science ®Google Scholar
• Li Q , ZhangR, FuJLet al. The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection. Zhonghua Zhong Liu Za Zhi44(11), 1194–1201 (2022).
   PubMedGoogle Scholar
• Li S , LanX, GaoHet al. Systemic inflammation response index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J. Cancer Res. Clin. Oncol.143(12), 2455–2468 (2017).
   PubMed Web of Science ®Google Scholar
• Li S , XuH, WangWet al. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma. Cancer Manag. Res.11, 3327–3337 (2019).
   PubMed Web of Science ®Google Scholar
• Li W , PengQW, LinYet al. A model to predict the recurrence of middle–high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes. Zhonghua Wei Chang Wai Ke Za Zhi23(9), 896–903 (2020).
   PubMedGoogle Scholar
• Liu Z , GeH, MiaoZet al. Dynamic changes in the systemic inflammation response index predict the outcome of resectable gastric cancer patients. Front. Oncol.11, 577043 (2021).
   PubMed Web of Science ®Google Scholar
• Pacheco-Barcia V , MondéjarSolís R, FranceTet al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology20(2), 254–264 (2020).
   PubMed Web of Science ®Google Scholar
• Qi WX , WangX, LiCet al. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: an analysis from a prospective cohort. Thorac. Cancer14(17), 1556–1566 (2023).
   PubMed Web of Science ®Google Scholar
• Sun L , HuW, LiuMet al. High systemic inflammation response index (SIRI) indicates poor outcome in gallbladder cancer patients with surgical resection: a single institution experience in China. Cancer Res. Treat.52(4), 1199–1210 (2020).
   PubMed Web of Science ®Google Scholar
• Topkan E , SelekU, PehlivanBet al. The prognostic significance of novel pancreas cancer prognostic index in unresectable locally advanced pancreas cancers treated with definitive concurrent chemoradiotherapy. J. Inflamm. Res.14, 4433–4444 (2021).
   PubMed Web of Science ®Google Scholar
• Wang SB , ChenJY, XuCet al. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection. Front. Oncol.12, 1040495 (2022).
   PubMed Web of Science ®Google Scholar
• Wang TC , AnTZ, LiJX, PangPF. Systemic inflammation response index is a prognostic risk factor in patients with hepatocellular carcinoma undergoing TACE. Risk Manag. Healthc. Policy14, 2589–2600 (2021).
   PubMed Web of Science ®Google Scholar
• Wu Y , TuC, ShaoC. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy. BMC Surg.21(1), 178 (2021).
   PubMed Web of Science ®Google Scholar
• Xin Y , ZhangX, LiYet al. A systemic inflammation response index (SIRI)-based nomogram for predicting the recurrence of early stage hepatocellular carcinoma after radiofrequency ablation. Cardiovasc. Intervent. Radiol.45(1), 43–53 (2022).
   PubMed Web of Science ®Google Scholar
• Xu L , YuS, ZhuangLet al. Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget8(21), 34954–34960 (2017).
   PubMedGoogle Scholar
• Yan K , WeiW, ShenWet al. Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy. J. Gastrointest. Oncol.13(1), 13–25 (2022).
   PubMed Web of Science ®Google Scholar
• Yazici H , YegenSC. Is systemic inflammatory response index (SIRI) a reliable tool for prognosis of gastric cancer patients without neoadjuvant therapy?Cureus15(3), e36597 (2023).
   PubMed Web of Science ®Google Scholar
• Ying HQ , LiaoYC, SunFet al. The role of cancer-elicited inflammatory biomarkers in predicting early recurrence within stage II–III colorectal cancer patients after curable resection. J. Inflamm. Res.14, 115–129 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang J , DingY, WangWet al. Combining the fibrinogen/albumin ratio and systemic inflammation response index predicts survival in resectable gastric cancer. Gastroenterol. Res. Pract.2020, 3207345 (2020).
   PubMed Web of Science ®Google Scholar
• Zhao M , DuanX, MiLet al. Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index. Future Oncol.18(18), 2269–2288 (2022).
   PubMed Web of Science ®Google Scholar
• Zhou Q , SuS, YouWet al. Systemic inflammation response index as a prognostic marker in cancer patients: a systematic review and meta-analysis of 38 cohorts. Dose Response19(4), 15593258211064744 (2021).
   Web of Science ®Google Scholar
• Khandia R , MunjalA. Interplay between inflammation and cancer. Adv. Protein Chem. Struct. Biol.119, 199–245 (2020).
   PubMed Web of Science ®Google Scholar
• Mantovani A , AllavenaP, SicaA, BalkwillF. Cancer-related inflammation. Nature454(7203), 436–444 (2008).
   PubMed Web of Science ®Google Scholar
• Tian BW , YangYF, YangCCet al. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy14(18), 1481–1496 (2022).
   PubMed Web of Science ®Google Scholar
• Ocana A , Nieto-JiménezC, PandiellaA, TempletonAJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol. Cancer16(1), 137 (2017).
   PubMedGoogle Scholar
• Xiong S , DongL, ChengL. Neutrophils in cancer carcinogenesis and metastasis. J. Hematol. Oncol.14(1), 173 (2021).
   PubMed Web of Science ®Google Scholar
• Jaillon S , PonzettaA, DiMitri Det al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer20(9), 485–503 (2020).
   PubMed Web of Science ®Google Scholar
• Mantovani A , SchioppaT, PortaCet al. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev25(3), 315–322 (2006).
   PubMed Web of Science ®Google Scholar
• Huang C , LiZ, LiNet al. Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice. Gastroenterology154(3), 675–688 (2018).
   PubMed Web of Science ®Google Scholar
• Ugel S , CanèS, DeSanctis F, BronteV. Monocytes in the tumor microenvironment. Annu. Rev. Pathol.16, 93–122 (2021).
   PubMed Web of Science ®Google Scholar
• Gonzalez H , HagerlingC, WerbZ. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev.32(19–20), 1267–1284 (2018).
   PubMed Web of Science ®Google Scholar
• Wu ES , OduyeboT, CobbLPet al. Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecol. Oncol.140(1), 76–82 (2016).
   PubMed Web of Science ®Google Scholar